Advances in topiramate as prophylactic treatment for migraine
Authors:
Open Access
- 2 September 2021
- journal article
- review article
- Published by Wiley in Brain and Behavior
- Vol. 11 (10)
Abstract
It is well‐known that topiramate as a kind of antiepileptic drug has been proved effective for migraine prevention in North America and Europe. However, topiramate is still viewed as an off‐label medication for migraine treatment in China, partly because of the limited evidence in Chinese patients. We summarize the effects of topiramate on the frequency, severity, quality‐of‐life, and adverse event among migraine patients, including children and adolescent in this review, so as to provide reference for Chinese doctors.Keywords
This publication has 29 references indexed in Scilit:
- Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: [RETIRED]Neurology, 2012
- EFNS guideline on the drug treatment of migraine – revised report of an EFNS task forceEuropean Journal of Neurology, 2009
- Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for Migraine Prevention in Pediatric Subjects 12 to 17 Years of AgePediatrics, 2009
- The Impact of Topiramate on Health‐Related Quality of Life Indicators in Chronic MigraineHeadache: The Journal of Head and Face Pain, 2007
- Topiramate for Migraine Prophylaxis Among Chinese PopulationHeadache: The Journal of Head and Face Pain, 2007
- Low‐Dose Topiramate Versus Lamotrigine in Migraine Prophylaxis (The Lotolamp Study)Headache: The Journal of Head and Face Pain, 2006
- Repression of Stimulated Calcitonin Gene‐Related Peptide Secretion by TopiramateHeadache: The Journal of Head and Face Pain, 2006
- Topiramate for Migraine Prevention in Children: A Randomized, Double‐Blind, Placebo‐Controlled TrialHeadache: The Journal of Head and Face Pain, 2005
- Topiramate in Migraine Prevention: A Double‐Blind, Placebo‐Controlled StudyHeadache: The Journal of Head and Face Pain, 2001
- Topiramate as an Inhibitor of Carbonic Anhydrase IsoenzymesEpilepsia, 2000